Skip to main content
Law360

Medical Device Cases Show Increased Sunshine Act Scrutiny

June 11, 2021
Authors
Jaime L.M. Jones

The U.S. Department of Justice recently announced its second False Claims Act settlement within the past half year resolving allegations that transfers of value not only violated the Anti-Kickback Statute, but also went unreported to the Centers for Medicare & Medicaid Services, in violation of the Sunshine Act.

View Article

Contacts

Jones, Jaime L.M.
Partner

Related Blogs

Capabilities

Suggested News & Insights

Exclusive Fireside Chat: A Conversation With FDA's Chief CounselTuesday, January 12, 2027
Conferences
Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027
Conferences
U.S. Treasury Proposes Sweeping Limits on U.S. Investments in “Countries of Concern”: Biotechnology, Super Intelligence, and MoreOctober 28, 2026
Global Arbitration, Trade and Advocacy Update
Major Medicare Part D Pharmacy Benefit Manager Reforms Proposed by CMS for CommentOctober 27, 2026
Global Life Sciences Update
District of Massachusetts Rejects Per Se AKS Liability for Commissioned, Independent Contractor Sales Representatives But Allows FCA Claims to ProceedOctober 26, 2026
Original Source
DOJ Launches Criminal and Civil Self-Disclosure Programs Relevant to Healthcare and Life Sciences CompaniesOctober 26, 2026
Healthcare Update